Drug therapy adherence and health outcomes in the presence of physician and patient unobserved heterogeneity
- 21 September 2017
- journal article
- research article
- Published by Wiley in Health Economics
- Vol. 26 (S2) , 106-126
Abstract
Understanding the role that drug adherence has on health outcomes in everyday clinical practice is central for the policy maker. This is particularly true when patients suffer from asymptomatic chronic conditions (e.g., hypertension, hypercholesterolaemia, and diabetes). By exploiting a unique longitudinal dataset at patient and physician level in Italy, we show that patients and physicians unobserved characteristics play an important role in determining health status, at least as important as drug adherence. Most importantly, we find that both adherence and prescribed treatment regimen effects are highly heterogeneous across physicians, highlighting their crucial role in shaping patients' health status.Keywords
All Related Versions
This publication has 41 references indexed in Scilit:
- Attrition Bias in Panel Data: A Sheep in Wolf's Clothing? A Case Study Based on the Mabel SurveyHealth Economics, 2015
- Who is responsible for your health: is it you, your doctor or the new technologies?The European Journal of Health Economics, 2014
- The impact of cost-sharing schemes on drug compliance in Italy: evidence based on quantile regressionInternational Journal of Public Health, 2013
- Heterogeneity in Cost-Sharing and Cost-Sensitivity, and the Role of the Prescribing Physician2013
- Disentangling True Determinants of Drug Therapy Effectiveness: A Double Fixed Effects ApproachSSRN Electronic Journal, 2011
- Beyond Low-Density Lipoprotein CholesterolJACC, 2009
- Drug compliance, co-payment and health outcomes: evidence from a panel of Italian patientsHealth Economics, 2006
- Relationship of Blood Pressure Control to Adherence With Antihypertensive Monotherapy in 13 Managed Care OrganizationsJournal of Managed Care Pharmacy, 2006
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statinsThe Lancet, 2005
- High Wage Workers and High Wage FirmsEconometrica, 1999